| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Lilly Research Laboratories, Department of Gene Regulation, Bone and Inflammation Research, Eli Lilly & Co., Indianapolis, Indiana 46285
Address all correspondence and requests for reprints to: Dr. Lan Ko, Department of Gene Regulation, Bone & Inflammation Research, Lilly Corporate Center, Building 98/C, Drop Code 0434, Indianapolis, Indiana 46285. E-mail: kol{at}lilly.com
Ligand-dependent interaction of nuclear receptors and coactivators
is a critical step in nuclear receptor-mediated transcriptional
regulation. TR-binding protein (TRBP) interacts with nuclear receptors
through a single LXXLL motif. Evidence suggested that the sequences
flanking the LXXLL motif in a number of coactivators determine receptor
selectivity. We performed mutagenesis studies at residues adjacent to
the TRBP LXXLL motif and identified S884 of TRBP at the -3 position of
the LXXLL motif as a key residue for receptor selectivity. Analysis of
in vitro and in vivo receptor
interactions with TRBP suggested that S884 allowed selective
interactions for ERß, TR, and RXR vs. ER
. Transient
transfection studies further confirmed that the LXXLL-binding affinity
correlates with TRBP transcriptional activity. Consistent with the
structural modeling, an E380G substitution within ER
altered the
binding to TRBP mutants, demonstrating the direct contact between TRBP
S884 and ER
E380, which is a residue that distinguishes receptor
subclasses. Furthermore, S884 can be phosphorylated by MAPK in
vitro, an event that significantly altered the binding of TRBP
to ER and suggests a potential mechanism for regulatory interaction. As
the differential recruitment of TRBP to ER
and ERß may rely on
S884, our finding provides insight into estrogen signaling and may lead
to the development of therapeutic receptor-selective peptide
antagonists.
This article has been cited by other articles:
![]() |
H. J. Dubbink, R. Hersmus, A. C. W. Pike, M. Molier, A. O. Brinkmann, G. Jenster, and J. Trapman Androgen Receptor Ligand-Binding Domain Interaction and Nuclear Receptor Specificity of FXXLF and LXXLL Motifs as Determined by L/F Swapping Mol. Endocrinol., August 1, 2006; 20(8): 1742 - 1755. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Mahajan and H. H. Samuels Nuclear Hormone Receptor Coregulator: Role in Hormone Action, Metabolism, Growth, and Development Endocr. Rev., June 1, 2005; 26(4): 583 - 597. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Liu, B. O. Kim, C. Kao, C. Jung, J. T. Dalton, and J. J. He Tip110, the Human Immunodeficiency Virus Type 1 (HIV-1) Tat-interacting Protein of 110 kDa as a Negative Regulator of Androgen Receptor (AR) Transcriptional Activation J. Biol. Chem., May 21, 2004; 279(21): 21766 - 21773. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. L. Smith and B. W. O'Malley Coregulator Function: A Key to Understanding Tissue Specificity of Selective Receptor Modulators Endocr. Rev., February 1, 2004; 25(1): 45 - 71. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Takeuchi, H. H. Q. Heng, C. J. Ye, S.-B. Liang, J. Iwata, H. Sonobe, and Y. Ohtsuki Down-Regulation of a Novel Actin-Binding Molecule, Skeletrophin, in Malignant Melanoma Am. J. Pathol., October 1, 2003; 163(4): 1395 - 1404. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-M. Leduc, J. O. Trent, J. L. Wittliff, K. S. Bramlett, S. L. Briggs, N. Y. Chirgadze, Y. Wang, T. P. Burris, and A. F. Spatola Helix-stabilized cyclic peptides as selective inhibitors of steroid receptor-coactivator interactions PNAS, September 30, 2003; 100(20): 11273 - 11278. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. H. Coulthard, S. Matsuda, and D. M. Heery An Extended LXXLL Motif Sequence Determines the Nuclear Receptor Binding Specificity of TRAP220 J. Biol. Chem., March 21, 2003; 278(13): 10942 - 10951. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ko and W. W. Chin Nuclear Receptor Coactivator Thyroid Hormone Receptor-binding Protein (TRBP) Interacts with and Stimulates Its Associated DNA-dependent Protein Kinase J. Biol. Chem., March 21, 2003; 278(13): 11471 - 11479. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. He and E. M. Wilson Electrostatic Modulation in Steroid Receptor Recruitment of LXXLL and FXXLF Motifs Mol. Cell. Biol., March 15, 2003; 23(6): 2135 - 2150. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wu, W. W. Chin, Y. Wang, and T. P. Burris Ligand and Coactivator Identity Determines the Requirement of the Charge Clamp for Coactivation of the Peroxisome Proliferator-activated Receptor gamma J. Biol. Chem., February 28, 2003; 278(10): 8637 - 8644. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y.-H. Goo, Y. C. Sohn, D.-H. Kim, S.-W. Kim, M.-J. Kang, D.-J. Jung, E. Kwak, N. A. Barlev, S. L. Berger, V. T. Chow, et al. Activating Signal Cointegrator 2 Belongs to a Novel Steady-State Complex That Contains a Subset of Trithorax Group Proteins Mol. Cell. Biol., January 1, 2003; 23(1): 140 - 149. [Abstract] [Full Text] |
||||
![]() |
T. Suzuki, M. Kasahara, H. Yoshioka, K.-i. Morohashi, and K. Umesono LXXLL-Related Motifs in Dax-1 Have Target Specificity for the Orphan Nuclear Receptors Ad4BP/SF-1 and LRH-1 Mol. Cell. Biol., January 1, 2003; 23(1): 238 - 249. [Abstract] [Full Text] |
||||
![]() |
R. Schiff, S. Massarweh, J. Shou, and C. K. Osborne Breast Cancer Endocrine Resistance: How Growth Factor Signaling and Estrogen Receptor Coregulators Modulate Response Clin. Cancer Res., January 1, 2003; 9(1): 447S - 454S. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. J. Malloy, R. Xu, L. Peng, P. A. Clark, and D. Feldman A Novel Mutation in Helix 12 of the Vitamin D Receptor Impairs Coactivator Interaction and Causes Hereditary 1,25-Dihydroxyvitamin D-Resistant Rickets without Alopecia Mol. Endocrinol., November 1, 2002; 16(11): 2538 - 2546. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. J. McKenna and B. W. O'Malley Minireview: Nuclear Receptor Coactivators--An Update Endocrinology, July 1, 2002; 143(7): 2461 - 2465. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |